Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China

BACKGROUND: Human papillomavirus (HPV) 16 and 18 are the two most common HPV oncogenic types that can be prevented by vaccination. This study aimed at assessing the cost-effectiveness of 3 doses of the bivalent HPV vaccine in rural and urban settings in China. METHODS: A Markov model was adapted to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qian, Liu, Yi-Jun, Hu, Shang-Ying, Zhao, Fang-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097411/
https://www.ncbi.nlm.nih.gov/pubmed/27814703
http://dx.doi.org/10.1186/s12885-016-2893-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097411/
https://www.ncbi.nlm.nih.gov/pubmed/27814703
http://dx.doi.org/10.1186/s12885-016-2893-x

Ejemplares similares